Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Teva expects Allergan deal close any day, it says while lifting guidance
Teva expects Allergan deal close any day, it says while lifting guidance
Teva and Allergan are extending the deadline once again for their $40.
Cipla to pump $89M into building South African biosimilars plant
Cipla to pump $89M into building South African biosimilars plant
India’s Cipla said it will invest $89 million (1.
Global Active Pharmaceutical Ingredients (API) Market Revenues to Reach US$ 143 Bn in 2016, With North America Accounting for 35% Revenue Shares
Global Active Pharmaceutical Ingredients (API) Market Revenues to Reach US$ 143 Bn in 2016, With North America Accounting for 35% Revenue Shares
NEW YORK, July 11, 2016 /PRNewswire/ -- According to a New Market Report Published by Persistence Market Research "Active Pharmaceutical Ingredient (API) Market" the Global Active Ph...
FDA Approves Shire’s Xiidra™ (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease
FDA Approves Shire’s Xiidra™ (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease
Lexington, Mass.
Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction
Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction
TOKYO & SCHAUMBURG, Ill.
Sage's drug for postpartum depression succeeds in mid-stage study
Sage's drug for postpartum depression succeeds in mid-stage study
Sage Therapeutics Inc said its lead drug alleviated symptoms of severe postpartum depression, meeting the main goal of a small mid-stage study and sending the company's shares soaring in morning t...
Amgen drug appears 'highly similar' to Humira: FDA staff
Amgen drug appears 'highly similar' to Humira: FDA staff
Amgen Inc's version of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, appears similar in potency and safety to the original product, U.
European Commission approves Zinbryta to treat relapsing forms of multiple sclerosis
European Commission approves Zinbryta to treat relapsing forms of multiple sclerosis
The European Commission (EC) has approved Zinbryta (daclizumab) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS).
Women who take aspirin before sex are more likely to give birth to a baby boy
Women who take aspirin before sex are more likely to give birth to a baby boy
Women who take an aspirin before sex may increase the likelihood of conceiving a baby boy, suggest researchers.
Chinese API maker spanked in warning letter
Chinese API maker spanked in warning letter
Some FDA warning letters are long, drawn-out documents listing specific and multiple violations and sometimes offering a blueprint for fixing issues.
Alexion making €100M Ireland plant investment
Alexion making €100M Ireland plant investment
Great Britain’s decision to bail on the European Union has raised questions about pharma investment on the continent but not stopped pharma companies from wanting to build manufacturing facilities i...
Novo expanding massive Denmark plant
Novo expanding massive Denmark plant
Just weeks after kicking off construction of a nearly $2 billion API plant in the U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand